161 related articles for article (PubMed ID: 9422112)
1. The role of different histocompatibility testing methods for selection of related and unrelated bone marrow donors.
Oudshoorn M; van Leeuwen A; van Rood JJ
Beitr Infusionsther Transfusionsmed; 1994; 32():250-5. PubMed ID: 9422112
[TBL] [Abstract][Full Text] [Related]
2. Problems and possible solutions in finding an unrelated bone marrow donor. Results of consecutive searches for 240 Dutch patients.
Oudshoorn M; Cornelissen JJ; Fibbe WE; de Graeff-Meeder ER; Lie JL; Schreuder GM; Sintnicolaas K; Willemze R; Vossen JM; van Rood JJ
Bone Marrow Transplant; 1997 Dec; 20(12):1011-7. PubMed ID: 9466272
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor?
Tiercy JM; Bujan-Lose M; Chapuis B; Gratwohl A; Gmür J; Seger R; Kern M; Morell A; Roosnek E
Bone Marrow Transplant; 2000 Aug; 26(4):437-41. PubMed ID: 10982291
[TBL] [Abstract][Full Text] [Related]
4. Relation between the resolution of HLA-typing and the chance of finding an unrelated bone marrow donor.
Speiser DE; Tiercy JM; Rufer N; Chapuis B; Morell A; Kern M; Gmür J; Gratwohl A; Roosnek E; Jeannet M
Bone Marrow Transplant; 1994 Jun; 13(6):805-9. PubMed ID: 7920318
[TBL] [Abstract][Full Text] [Related]
5. Histocompatibility and bone marrow transplantation (BMT).
Richter KV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):445-50. PubMed ID: 2480287
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
Russell CA
Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
[TBL] [Abstract][Full Text] [Related]
7. [Immunological selection of bone marrow donors].
Toungouz-Névessignsky M; Andrien M; Dupont E
Rev Med Brux; 1992 May; 13(5):152, 155-9. PubMed ID: 1609189
[TBL] [Abstract][Full Text] [Related]
8. HLA and bone marrow transplant donor search strategies.
Agrawal S; Bhardwaj U
J Assoc Physicians India; 2002 Jul; 50():937-45. PubMed ID: 12126352
[TBL] [Abstract][Full Text] [Related]
9. The unrelated bone marrow donor.
van Rood JJ; Zwaan FE; Willemze R
Bone Marrow Transplant; 1988 Sep; 3(5):371-7. PubMed ID: 3142631
[TBL] [Abstract][Full Text] [Related]
10. [Transplantation immunology in allogeneic bone marrow transplantation. The significance of HLA-tissue crossmatching between donors and recipients].
Egeland T; Thorsby E
Tidsskr Nor Laegeforen; 1994 Jan; 114(3):319-22. PubMed ID: 8191429
[TBL] [Abstract][Full Text] [Related]
11. Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation.
Souillet G; Rey S; Bertrand Y; Pujol M; Pondarré C; Bourgeot JP; Raba M; Eljaafari A; Chapuis F; Manel AM; Philippe N; Gebuhrer L
Bone Marrow Transplant; 2000 Jul; 26(1):31-43. PubMed ID: 10918403
[TBL] [Abstract][Full Text] [Related]
12. Helper and cytotoxic T cell precursor frequencies are not predictive for development of acute graft-versus-host disease after partially T cell-depleted HLA-identical sibling BMT.
van der Meer A; Allebes WA; Voorter CE; van den Berg-Loonen EM; Schattenberg AV; de Witte TJ; Joosten I
Bone Marrow Transplant; 1998 Dec; 22(11):1049-55. PubMed ID: 9877266
[TBL] [Abstract][Full Text] [Related]
13. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte precursor frequency as a predictor of acute graft-versus-host disease in bone marrow transplantation from HLA-identical siblings.
Affaticati P; Locatelli F; Roggero S; Marmont F; Falda M; Dall'Omo AM; Busca A; Ceretto C; Praticò L; Berrino M; Curtoni ES
Bone Marrow Transplant; 2000 Sep; 26(5):517-23. PubMed ID: 11019841
[TBL] [Abstract][Full Text] [Related]
15. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
16. [Donor selection for allogenic bone marrow transplantation from 1991 to 1995. (The Prague Center for Bone Marrow Transplantation)].
Korínková P; Matĕjková E; Vítek A
Cas Lek Cesk; 1996 Jun; 135(12):389-92. PubMed ID: 8706078
[TBL] [Abstract][Full Text] [Related]
17. [New possibilities of donor selection for bone marrow and organ transplantation by HLA typing and genomic DNA].
Lattermann A; Schoppet M; Mueller-Eckhardt G
Beitr Infusionsther Transfusionsmed; 1994; 32():256-60. PubMed ID: 9480102
[TBL] [Abstract][Full Text] [Related]
18. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
[TBL] [Abstract][Full Text] [Related]
19. Reliability of HLA-Cw data collected in unrelated bone marrow registry and their usefulness for preliminary donor selection.
Nowak J; Mika-Witkowska R; Zajko M; Łopacz P
Int J Immunogenet; 2005 Oct; 32(5):319-22. PubMed ID: 16164700
[TBL] [Abstract][Full Text] [Related]
20. [Significance and features of MLC reaction in histocompatibility determination of donor and recipient in allogenic bone marrow transplantation to patients with hematological malignancies].
Shpakova AP; Bulycheva TI; Liubimova LS; Mendeleeva LP
Ter Arkh; 2000; 72(11):62-7. PubMed ID: 11229316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
